Freestone Grove Partners LP Abbott Laboratories Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Abbott Laboratories stock. As of the latest transaction made, Freestone Grove Partners LP holds 918,608 shares of ABT stock, worth $117 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
918,608
Previous 90,883
910.76%
Holding current value
$117 Million
Previous $12.1 Billion
936.36%
% of portfolio
0.94%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,605Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22.1 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.68 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.33 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $224B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...